235 related articles for article (PubMed ID: 23276383)
21. A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma.
Teske E; Rutteman GR; Kirpenstein J; Hirschberger J
Vet Comp Oncol; 2011 Dec; 9(4):283-9. PubMed ID: 22077409
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of tumour-related factors associated with canine retroperitoneal hemangiosarcoma in comparison with other anatomic presentations: A retrospective observational study.
Furukawa T; Shiotsuki A; Okada Y; Nibe K; Tei M; Anazawa T; Yoshikawa M; Ono K; Hirao H
Vet Med Sci; 2024 Jul; 10(4):e1495. PubMed ID: 38889089
[TBL] [Abstract][Full Text] [Related]
23. Contrast harmonic ultrasonography of splenic masses and associated liver nodules in dogs.
Ivancić M; Long F; Seiler GS
J Am Vet Med Assoc; 2009 Jan; 234(1):88-94. PubMed ID: 19119970
[TBL] [Abstract][Full Text] [Related]
24. Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985).
Prymak C; McKee LJ; Goldschmidt MH; Glickman LT
J Am Vet Med Assoc; 1988 Sep; 193(6):706-12. PubMed ID: 3192450
[TBL] [Abstract][Full Text] [Related]
25. An immunohistochemical analysis of canine haemangioma and haemangiosarcoma.
Sabattini S; Bettini G
J Comp Pathol; 2009; 140(2-3):158-68. PubMed ID: 19091326
[TBL] [Abstract][Full Text] [Related]
26. Splenic masses in dogs. Part 1: Epidemiologic, clinical characteristics as well as histopathologic diagnosis in 249 cases (2000-2011).
Eberle N; von Babo V; Nolte I; Baumgärtner W; Betz D
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):250-60. PubMed ID: 22911256
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary Oncology.
Marconato L; Chalfon C; Finotello R; Polton G; Vasconi ME; Annoni M; Stefanello D; Mesto P; Capitani O; Agnoli C; Amati M; Sabattini S
Vet Comp Oncol; 2019 Dec; 17(4):537-544. PubMed ID: 31251441
[TBL] [Abstract][Full Text] [Related]
28. The addition of metronomic chemotherapy does not improve outcome for canine splenic haemangiosarcoma.
Alexander CK; Cronin KL; Silver M; Gardner HL; London C
J Small Anim Pract; 2019 Jan; 60(1):32-37. PubMed ID: 30209807
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of clinical and histologic factors associated with survival time in dogs with stage II splenic hemangiosarcoma treated by splenectomy and adjuvant chemotherapy: 30 cases (2011-2014).
Moore AS; Rassnick KM; Frimberger AE
J Am Vet Med Assoc; 2017 Sep; 251(5):559-565. PubMed ID: 28828962
[TBL] [Abstract][Full Text] [Related]
30. Questions data in study on hemangiosarcomas in dogs.
George JW
J Am Vet Med Assoc; 2008 Apr; 232(8):1133-4; author reply 1134. PubMed ID: 18441615
[No Abstract] [Full Text] [Related]
31. Epithelioid haemangiosarcoma in the ocular tissue of horses.
Arenas-Gamboa AM; Mansell J
J Comp Pathol; 2011 May; 144(4):328-33. PubMed ID: 21251669
[TBL] [Abstract][Full Text] [Related]
32. Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomy.
Faroni E; Sabattini S; Guerra D; Iannuzzi C; Chalfon C; Agnoli C; Stefanello D; Polton G; Ramos S; Aralla M; Ciaccini R; Foglia A; Okonji S; Marconato L
Vet Comp Oncol; 2023 Mar; 21(1):123-130. PubMed ID: 36633399
[TBL] [Abstract][Full Text] [Related]
33. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
[TBL] [Abstract][Full Text] [Related]
34. Case records of the Angell Memorial Animal Hospital.
J Am Vet Med Assoc; 1968 Aug; 153(3):325-30. PubMed ID: 5690701
[No Abstract] [Full Text] [Related]
35. A retrospective study of canine hemangiosarcoma and its association with acanthocytosis.
Hirsch VM; Jacobsen J; Mills JH
Can Vet J; 1981 May; 22(5):152-5. PubMed ID: 7195770
[TBL] [Abstract][Full Text] [Related]
36. Canine hemangiosarcoma treated with standard chemotherapy and minocycline.
Sorenmo K; Duda L; Barber L; Cronin K; Sammarco C; Usborne A; Goldschmidt M; Shofer F
J Vet Intern Med; 2000; 14(4):395-8. PubMed ID: 10935889
[TBL] [Abstract][Full Text] [Related]
37. Retrospective comparison of first-line adjuvant anthracycline vs metronomic-based chemotherapy protocols in the treatment of stage I and II canine splenic haemangiosarcoma.
Treggiari E; Borrego JF; Gramer I; Valenti P; Harper A; Finotello R; Toni C; Laomedonte P; Romanelli G
Vet Comp Oncol; 2020 Mar; 18(1):43-51. PubMed ID: 31648405
[TBL] [Abstract][Full Text] [Related]
38. Dynamic left ventricular outflow tract obstruction secondary to hypovolemia in a German Shepard dog with splenic hemangiosarcoma.
Aoki T; Sunahara H; Sugimoto K; Ito T; Kanai E; Neo S; Fujii Y; Wakao Y
J Vet Med Sci; 2015 Sep; 77(9):1187-90. PubMed ID: 25924797
[TBL] [Abstract][Full Text] [Related]
39. Canine splenic hemangiosarcoma with abdominal dissemination.
Zhao D; Yamaguchi R; Tateyama S; Ogawa H; Yamazaki Y
J Vet Med Sci; 1994 Aug; 56(4):753-5. PubMed ID: 7999902
[TBL] [Abstract][Full Text] [Related]
40. Big endothelin-1 as a tumour marker for canine haemangiosarcoma.
Fukumoto S; Miyasho T; Hanazono K; Saida K; Kadosawa T; Iwano H; Uchide T
Vet J; 2015 Jun; 204(3):269-74. PubMed ID: 25920760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
